Materna Prep Study Phase II

PHASE2CompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

September 8, 2021

Primary Completion Date

March 23, 2023

Study Completion Date

October 12, 2023

Conditions
Vaginal DeliveryPelvic Organ Prolapse
Interventions
DEVICE

Materna Prep Device

Subjects are treated with Materna Prep Device prior to vaginal delivery

Trial Locations (15)

10032

Columbia University Irving Medical Center, New York

19140

Lewis Katz School of Medicine at Temple, Philadelphia

19718

Christiana Care - Center for Women's & Children's Health, Newark

Hospital of the University of Pennsylvania, Philadelphia

35233

University of Alabama at Birmingham, Birmingham

43210

The Ohio State University Wexner Medical Center, Columbus

44109

The Metro Health System, Cleveland

55905

Mayo Clinic, Rochester

77030

Baylor College of Medicine, Houston

90095

University of California Los Angeles, Los Angeles

94040

El Camino Hospital, Mountain View

97239

Oregon Health and Science University, Portland

08103

The Cooper Health System, Camden

08901

Rutgers Robert Wood Johnson University Hospital, New Brunswick

07103

Rutgers New Jersey Medical School, Newark

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Materna Medical

INDUSTRY

NCT06126328 - Materna Prep Study Phase II | Biotech Hunter | Biotech Hunter